Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | 6-phosphofructo-2-kinase 2 | 0.157 | 0.9827 | 0.9706 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.1597 | 1 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0134 | 0.0614 | 0.0614 |
Onchocerca volvulus | 0.1597 | 1 | 0.5 | |
Brugia malayi | MH2 domain containing protein | 0.0134 | 0.0614 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.157 | 0.9827 | 0.9827 |
Loa Loa (eye worm) | hypothetical protein | 0.1597 | 1 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0056 | 0.0113 | 0.1849 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0056 | 0.0113 | 0.1849 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.1597 | 1 | 1 |
Mycobacterium ulcerans | fructose-2,6-bisphosphatase GpmB | 0.0943 | 0.5801 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.157 | 0.9827 | 0.9706 |
Mycobacterium ulcerans | hypothetical protein | 0.0943 | 0.5801 | 0.5 |
Schistosoma mansoni | 6-phosphofructokinase | 0.1597 | 1 | 1 |
Giardia lamblia | Hypothetical protein | 0.0943 | 0.5801 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.0113 | 0.0113 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.1597 | 1 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0056 | 0.0113 | 0.0113 |
Giardia lamblia | Hypothetical protein | 0.0943 | 0.5801 | 0.5 |
Entamoeba histolytica | phosphoglycerate mutase family protein, putative | 0.0943 | 0.5801 | 0.5 |
Echinococcus multilocularis | 6 phosphofructo 2 kinase:fructose 2 | 0.1597 | 1 | 0.5 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.157 | 0.9827 | 0.9706 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0134 | 0.0614 | 0.0614 |
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.1597 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0916 | 0.5628 | 0.5628 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.157 | 0.9827 | 0.9706 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (functional) | = 94 % | Antitubercular activity against Mycobacterium tuberculosis H37Rv MTCC 200 assessed as growth inhibition at MIC by L.J. MIC method | ChEMBL. | No reference |
Inhibition (functional) | = 99 % | Antitubercular activity against Mycobacterium tuberculosis H37Rv MTCC 200 assessed as growth inhibition at 6.25 ug/ml by BACTEC MGIT method | ChEMBL. | No reference |
MIC (functional) | = 0.25 ug ml-1 | Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 assessed as inhibition of complete maturation into schizonts after 40 hr | ChEMBL. | No reference |
MIC (functional) | = 6.25 ug ml-1 | Antitubercular activity against Mycobacterium tuberculosis H37Rv MTCC 200 assessed as growth inhibition by BACTEC MGIT method | ChEMBL. | No reference |
MIC (functional) | = 100 ug ml-1 | Antitubercular activity against Mycobacterium tuberculosis H37Rv MTCC 200 assessed as growth inhibition by L.J. MIC method | ChEMBL. | No reference |
MIC99 (functional) | = 200 ug ml-1 | Antimicrobial activity against Escherichia coli MTCC 443 assessed as growth inhibition by broth microdilution method | ChEMBL. | No reference |
MIC99 (functional) | = 250 ug ml-1 | Antimicrobial activity against Candida albicans MTCC 227 assessed as growth inhibition by broth microdilution method | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.